Browse Category

Stock Market News 14 November 2025

Anavex Life Sciences (AVXL) Stock Plunges After EMA Issues Negative Trend Vote on Alzheimer’s Drug

Anavex Life Sciences (AVXL) Stock Plunges After EMA Issues Negative Trend Vote on Alzheimer’s Drug

Anavex Life Sciences (NASDAQ: AVXL) tumbled on November 14, 2025 after Europe’s drug regulator delivered a negative trend vote on its Alzheimer’s candidate blarcamesine. The company plans a CHMP re-examination and a fresh meeting with the FDA. Here’s what happened
IREN Limited (IREN) Stock Plunges 12% as AI ‘Neocloud’ Trade Stumbles – Despite $9.7B Microsoft Deal (14 November 2025)

IREN Limited (IREN) Stock Plunges 12% as AI ‘Neocloud’ Trade Stumbles – Despite $9.7B Microsoft Deal (14 November 2025)

IREN Limited (NASDAQ: IREN) – the Australian-born Bitcoin miner turned renewable-powered AI data‑center operator – is having another wild session on Friday, 14 November 2025. Despite landing a landmark US$9.7 billion AI cloud contract with Microsoft earlier this month and
MDA Space Stock Plunges Over 50% on SpaceX Shock, But Q3 2025 Earnings and Wireless Power Deal Rekindle Bull Hopes

MDA Space Stock Plunges Over 50% on SpaceX Shock, But Q3 2025 Earnings and Wireless Power Deal Rekindle Bull Hopes

Canadian space-tech champion MDA Space faces a brutal rerating after EchoStar’s $1.3 billion contract cancellation and SpaceX‑linked customer buzz – just as it reports surging Q3 revenue, reaffirms guidance, and announces a futuristic wireless power partnership. MDA Space (TSX:MDA) stock
Stock Market Today, November 14, 2025: Global Sell-Off Deepens as Fed Rate-Cut Hopes Fade and Tech Rout Batters Dow, S&P 500, Nasdaq Futures

Stock Market Today, November 14, 2025: Global Sell-Off Deepens as Fed Rate-Cut Hopes Fade and Tech Rout Batters Dow, S&P 500, Nasdaq Futures

Global stock markets tumbled on Friday, November 14, 2025, as a wave of “higher for longer” interest-rate fears and mounting anxiety over lofty AI and tech valuations triggered another broad risk-off move from Asia to Wall Street. Zawya+3Reuters+3Reuters+3 Markets had
Pfizer Stock Surges 15% on Trump’s Pricing Pact & $7.3B Obesity Deal – Can the Rally Last?

Pfizer Stock (PFE) Before the Bell on November 14, 2025: Metsera Deal Closes, BioNTech Stake Cut and Guidance Raised

As Wall Street heads into Friday’s session, Pfizer stock is trading slightly lower in premarket action while investors digest a trio of big developments: the completed acquisition of obesity‑drug developer Metsera, a sharp reduction in Pfizer’s stake in BioNTech, and
1 721 722 723 724 725 939
Go toTop